{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T04:17:51Z","timestamp":1655525871531},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T00:00:00Z","timestamp":1401321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11739-014-1085-4","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T04:23:27Z","timestamp":1401251007000},"page":"617-622","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The value of inhibitors of factor Xa for the treatment of pulmonary embolism"],"prefix":"10.1007","volume":"9","author":[{"given":"Paolo","family":"Prandoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Temraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Barbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Pesavento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al\u00ec","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"key":"1085_CR1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11739-011-0725-1","volume":"8","author":"A Squizzato","year":"2013","unstructured":"Squizzato A, Luciani D, Rubboli A et al (2013) Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. Intern Emerg Med 8:695\u2013702","journal-title":"Intern Emerg Med"},{"key":"1085_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-140-3-200402030-00008","volume":"140","author":"DJ Quinlan","year":"2004","unstructured":"Quinlan DJ, McQuillan A, Eikelboom JW (2004) Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 140:175\u2013183","journal-title":"Ann Intern Med"},{"issue":"3 Suppl","key":"1085_CR3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.126.3_suppl.401S","volume":"126","author":"HR B\u00fcller","year":"2004","unstructured":"B\u00fcller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE (2004) Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 Suppl):401\u2013428","journal-title":"Chest"},{"key":"1085_CR4","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.CIR.102.22.2726","volume":"102","author":"The Rembrandt Investigators","year":"2000","unstructured":"The Rembrandt Investigators (2000) Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A\/ORG31540) with pure anti-factor Xa activity. A phase II evaluation. Circulation 102:2726\u20132731","journal-title":"Circulation"},{"key":"1085_CR5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa035451","volume":"349","author":"The Matisse Investigators","year":"2003","unstructured":"The Matisse Investigators (2003) Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349:1695\u20131702","journal-title":"N Engl J Med"},{"key":"1085_CR6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","volume":"140","author":"HR Buller","year":"2004","unstructured":"Buller HR, Davidson BL, Decousus H et al (2004) Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. Ann Intern Med 140:867\u2013873","journal-title":"Ann Intern Med"},{"issue":"2 Suppl","key":"1085_CR7","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C, Akl EA, Comerota AJ et al (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence\u2014Based Clinical Practice Guidelines. Chest 141(2 Suppl):e419S\u2013e494S","journal-title":"Chest"},{"key":"1085_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1538-7836.2003.00516.x","volume":"2","author":"The PERSIST Investigators","year":"2004","unstructured":"The PERSIST Investigators (2004) A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A phase II evaluation. J Thromb Haemost 2:47\u201353","journal-title":"J Thromb Haemost"},{"key":"1085_CR9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1056\/NEJMoa064247","volume":"357","author":"van Gogh Investigators","year":"2007","unstructured":"van Gogh Investigators (2007) Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med 357:1094\u20131104","journal-title":"N Engl J Med"},{"key":"1085_CR10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1538-7836.2010.04100.x","volume":"9","author":"The Equinox Investigators","year":"2011","unstructured":"The Equinox Investigators (2011) Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis. J Thromb Haemost 9:92\u201399","journal-title":"J Thromb Haemost"},{"key":"1085_CR11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(11)61505-5","volume":"379","author":"HR B\u00fcller","year":"2012","unstructured":"B\u00fcller HR, Gallus AS, Pillion G et al (2012) Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. Lancet 379:123\u2013129","journal-title":"Lancet"},{"key":"1085_CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11739-013-0948-4","volume":"8","author":"G Minno Di","year":"2013","unstructured":"Di Minno G, Ricciardi E, Scalera A (2013) Laboratory tests during direct oral anticoagulant treatment? No. Intern Emerg Med 8:367\u2013370","journal-title":"Intern Emerg Med"},{"key":"1085_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.106.668020","volume":"116","author":"G Agnelli","year":"2007","unstructured":"Agnelli G, Gallus A, Goldhaber SZ et al (2007) Treatment of proximal deep-vein thrombosis with the oral direct factor xa inhibitor rivaroxaban (BAY 59-7939). Circulation 116:180\u2013187","journal-title":"Circulation"},{"key":"1085_CR14","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2008-05-160143","volume":"112","author":"HR Buller","year":"2008","unstructured":"Buller HR, Lensing AW, Prins MH et al (2008) A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis. Blood 112:2242\u20132247","journal-title":"Blood"},{"key":"1085_CR15","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","volume":"363","author":"The Einstein Investigators","year":"2010","unstructured":"The Einstein Investigators (2010) Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363:2499\u20132510","journal-title":"N Engl J Med"},{"key":"1085_CR16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","volume":"366","author":"The Einstein Investigators","year":"2012","unstructured":"The Einstein Investigators (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366:1287\u20131297","journal-title":"N Engl J Med"},{"key":"1085_CR17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1538-7836.2007.02848.x","volume":"6","author":"H Buller","year":"2008","unstructured":"Buller H, Deitchman D, Prins M, Segers (2008) Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep-vein thrombosis. The Botticelli DVT dose-ranging study. J Thromb Haemost 6:1313\u20131318","journal-title":"J Thromb Haemost"},{"key":"1085_CR18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","volume":"369","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A et al (2013) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369:799\u2013808","journal-title":"N Engl J Med"},{"key":"1085_CR19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","volume":"369","author":"Hokusai-VTE Investigators","year":"2013","unstructured":"Hokusai-VTE Investigators (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369:1406\u20131415","journal-title":"N Engl J Med"},{"key":"1085_CR20","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1093\/eurheartj\/ehs258","volume":"33","author":"S Konstantinides","year":"2012","unstructured":"Konstantinides S, Goldhaber SZ (2012) Pulmonary embolism: risk assessment and management. Eur Heart J 33:3014\u20133022","journal-title":"Eur Heart J"},{"key":"1085_CR21","doi-asserted-by":"crossref","unstructured":"Pesavento R, Filippi L, Pagnan A, et al. (2014) Unexpected high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. Am J Respir Crit Care Med [Epub ahead of print]","DOI":"10.1164\/rccm.201312-2251LE"},{"key":"1085_CR22","doi-asserted-by":"crossref","unstructured":"Imberti D, Benedetti R. (2013) Practical Management of Rivaroxaban for the Treatment of Venous Thromboembolism. Clin Appl Thromb Hemost [Epub ahead of print]","DOI":"10.1177\/1076029613503397"},{"key":"1085_CR23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/14656566.2013.773310","volume":"14","author":"G Palareti","year":"2013","unstructured":"Palareti G, Ageno W, Ferrari A et al (2013) Clinical management of rivaroxaban-treated patients. Expert Opin Pharmacother 14:655\u2013667","journal-title":"Expert Opin Pharmacother"},{"key":"1085_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrcardio.2013.210","volume":"11","author":"P Prandoni","year":"2013","unstructured":"Prandoni P (2013) Venous thromboembolism in 2013: the advent of the novel oral anticoagulants. Nat Rev Cardiol 11:70\u201372","journal-title":"Nat Rev Cardiol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1085-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-014-1085-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-014-1085-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:28:48Z","timestamp":1559424528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-014-1085-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1007\/s11739-014-1085-4","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,29]]}}}